Pfizer (PFE) stock is up today after the pharmaceutical company reported earnings for the fourth quarter of 2024. The company ...

Pfizer Inc. (NYSE:PFE) discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the ...

Since the beginning of 2024, PFE stock has underperformed the S&P 500 index, delivering -3% returns compared to the index’s ...

The results cap off a critical year for Pfizer, which has been slashing costs as it recovers from the rapid decline of its ...

Pfizer's Q4 2024 earnings beat expectations, but concerns over 2025 guidance and patent expirations led to stock decline. See ...

In this article, we are going to take a look at where Pfizer Inc. (NYSE ... best balance of potential for both dividend growth and stock price appreciation. A report from Nuveen highlighted ...

Pfizer (PFE) reported fourth quarter and full-year 2024 earnings results Tuesday, narrowly beating Wall Street expectations ...

However, Pfizer's revenue guidance for 2025 doesn't look particularly exciting. The company expects its top line to come in between $61 billion and $64 billion -- the same projection it made for the ...

Stock prices can be irrational in the short term, but tend to follow earnings eventually. Pfizer's high dividend yield may have caught your attention, especially if you're a dividend investor.

Invest in essential sectors like consumer staples and energy to beat inflation. See why these stocks offer reliable dividends ...

Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from ...